Cargando…
Doxorubicin Inhibits Phosphatidylserine Decarboxylase and Modifies Mitochondrial Membrane Composition in HeLa Cells
Doxorubicin (DXR) is a drug widely used in chemotherapy. Its mode of action is based on its intercalation properties, involving the inhibition of topoisomerase II. However, few studies have reported the mitochondrial effects of DXR while investigating cardiac toxicity induced by the treatment, mostl...
Autores principales: | Bellance, Nadège, Furt, Fabienne, Melser, Su, Lalou, Claude, Thoraval, Didier, Maneta-Peyret, Lilly, Lacombe, Didier, Moreau, Patrick, Rossignol, Rodrigue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072979/ https://www.ncbi.nlm.nih.gov/pubmed/32075281 http://dx.doi.org/10.3390/ijms21041317 |
Ejemplares similares
-
A novel di-acidic motif facilitates ER export of the syntaxin SYP31
por: Chatre, Laurent, et al.
Publicado: (2009) -
The receptor kinase FERONIA regulates phosphatidylserine localization at the cell surface to modulate ROP signaling
por: Smokvarska, Marija, et al.
Publicado: (2023) -
Phosphatidylserine synthase 2 and phosphatidylserine decarboxylase are essential for aminophospholipid synthesis in T
rypanosoma brucei
por: Farine, Luce, et al.
Publicado: (2017) -
Conditional targeting of phosphatidylserine decarboxylase to lipid droplets
por: Kumar, Santosh, et al.
Publicado: (2021) -
High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy
por: Imasawa, Toshiyuki, et al.
Publicado: (2017)